anagliptin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
dipeptidyl aminopeptidase-IV inhibitors 4896 739366-20-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • anagliptin HCl
  • anagliptin
  • beskoa
  • anagliptin hydrochloride
  • suiny
anagliptin hydrochloride salt is the active compound
  • Molecular weight: 383.46
  • Formula: C19H25N7O2
  • CLOGP: 1.17
  • LIPINSKI: 0
  • HAC: 9
  • HDO: 2
  • TPSA: 115.42
  • ALOGS: -3.33
  • ROTB: 6

Drug dosage:

None

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

anagliptin